Lipopolysaccharide (Salmonella enterica)
Catalog Number: LPS0001
Price: Online Inquiry
Catalog Number: LPS0001
Price: Online Inquiry
| Product Information | |
|---|---|
| Size | 10mg |
| Description | As an inducing agent, to stimulate acute lung injury in human bronchial epithelial (HBE) cells; as a Toll-like receptor 4 (TLR4) agonist and stimulate normal intestinal fibroblasts (NF), to study the expression of fibroblast osteopontin (OPN); to study its impact on the expression of pro-inflammatory and pro-coagulant genes in endothelial cells. Purification method: Phenol extraction |
| Appearance | White to pale yellow powder |
| Content | Protein content < 3% |
| Source | Salmonella enterica serovar Minnesota |
| Properties | |
|---|---|
| Storage Conditions | Store at 2-8℃. |
| Shipping Conditions | Refrigerated Transport |
Lipopolysaccharide (LPS) is a pyrogenic element caused by enterobacteria such as Escherichia coli and intestinal Salmonella. It is an amphipathic component containing polysaccharides and lipid substances. LPS is present in the outer membrane of the cell wall of almost all Gram-negative bacteria. Lipopolysaccharide (LPS) is the characteristic component of the cell wall of Gram-negative bacteria. LPS and its lipid A component can stimulate innate immune system cells through Toll-like receptor 4 (TLR4), which is a member of the Toll-like receptor protein family, capable of recognizing common pathogen-associated molecular patterns (PAMPs).
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.